When Traditional Methods Fall Short
Calculating the binding of a single drug candidate takes weeks, and libraries contain millions of molecules. Quantum-chemical methods (DFT, MP2) are accurate but computationally too expensive to scale screening. AI models replace empirical potentials and quantum calculations, delivering comparable accuracy at hundreds of times faster speed. Our company develops turnkey AI molecular modeling platforms. With 5+ years of experience in AI/ML for pharma, we have helped 10+ projects reduce R&D time. Contact us for a project assessment.
Problems We Solve
Protein Structure Prediction
AlphaFold by DeepMind revolutionized this domain: predicting a protein’s 3D structure from its amino acid sequence now approaches experimental accuracy (X-ray crystallography, cryo-EM). The AlphaFold database contains 200M+ predicted structures. For drug discovery, a known 3D target protein structure enables structure-based drug design and virtual docking.
Molecular Docking
Classical methods (AutoDock Vina, Glide) are slow for screening millions of molecules. ML acceleration uses Neural Network Scoring Functions and Equivariant Neural Networks (SE(3)-Transformer). DiffDock, a recent development, provides accuracy comparable to AutoDock at 1000× speed. Its success rate (≤2Å RMSD) reached 38% versus 21% for the baseline.
Molecular Dynamics (MD) and ML Potentials
Traditional MD simulations require days of CPU time for nanosecond trajectories. Neural Network Potentials (ANI, NequIP, MACE) approximate DFT calculations 100–1000× faster while maintaining accuracy close to DFT/B3LYP for organic molecules. They scale to systems of millions of atoms.
Free Energy Perturbation (FEP) with ML
FEP is a key metric in lead optimization. ML-enhanced FEP (RBFE-ML) accelerates computing relative binding free energy differences while preserving accuracy.
How We Do It (Expertise Proof)
Our approach combines domain-specific architectures and transfer learning. For example, on a recent project for a kinase target, we integrated AlphaFold predictions with a custom graph neural network for scoring. The client had 500 known actives and 5 million compounds to screen. We fine-tuned a pre-trained SE(3)-equivariant model on their data, reducing inference time from 8 seconds per compound (AutoDock Vina) to 1.2 seconds with our ML scoring. The top 0.1% of predictions were experimentally validated with a 70% hit rate, saving months of wet-lab work.
What’s included:
- Data analysis and requirements specification
- Selection of model architectures (e.g., DiffDock, NequIP, custom GNN)
- Training on your data with cross-validation
- Integration into your IT infrastructure (API, web interface)
- Testing on representative cases
- Documentation and team training
Process and Timeline (No Fixed Price)
We follow a stage-gated process to minimize risk:
| Stage | Duration | Output |
|---|---|---|
| Data & requirements analysis | 2–3 weeks | Technical specification |
| Architecture selection & prototyping | 2–4 weeks | Model prototype |
| Training on your data | 4–10 weeks | Trained model with metrics |
| Integration with your infrastructure | 2–3 weeks | Working API/web interface |
| Testing on your use cases | 2–4 weeks | Accuracy and performance report |
| Documentation & training | 1–2 weeks | User guide, team onboarding |
Total timeline: from 4 to 8 months. Cost is determined after analysis. Contact us to pinpoint your case.
Typical Mistakes (Checklist)
- Ignoring data leakage: When splitting data, ensure no overlapping targets or similar scaffolds between train and test. We use time-based or cluster-based splits.
- Using rigid scoring functions for flexible binding: Many docking tools treat the protein as rigid. Our ML models can incorporate side-chain flexibility via ensemble docking or equivariant networks.
- Overfitting to public datasets: Pre-trained models from QM9 or PDBbind may not generalize to your specific target. We always fine-tune on your proprietary data.
Why Choose AI Modeling Over Traditional Methods?
Traditional methods (DFT, MD) are accurate but do not scale. AI models deliver comparable accuracy at speeds sufficient to screen millions of candidates. This reduces costly experiments — R&D budget savings can reach 60–80%. Our solutions include pre-trained models fine-tuned to your data, ensuring personalized accuracy. We guarantee quality and support at all stages. Get a consultation — contact us.